Our findings indicate that exposure to specific light conditions accelerates CLN3-dependent retinal degeneration, and that immunomodulation by minocycline could be a possible treatment option to delay vision loss in jNCL patients. Here, CLN3 is linked to juvenile neuronal ceroid lipofuscinosis.